Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
23.04. | Kane Biotech Inc (2): Kane Biotech sale of Stem Animal interest | 1 | Stockwatch | ||
16.04. | Kane Biotech Inc (2): Kane Biotech to hold webinar April 18 | 2 | Stockwatch | ||
16.04. | Kane Biotech Inc.: Kane Biotech to Host Investor Webinar | 1 | GlobeNewswire (USA) | ||
15.04. | Kane Biotech Inc (2): Kane Biotech closes STEM interest sale | 2 | Stockwatch | ||
15.04. | Kane Biotech Inc.: Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Products | 496 | GlobeNewswire (Europe) | WINNIPEG, Manitoba, April 15, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) ("Kane") announces that, it has completed the sale of its interest in STEM Animal Health Inc. to... ► Artikel lesen | |
11.04. | Kane Biotech to sell its STEM Animal Health for C$11.5 million | 1 | The Market Herald Canada | ||
11.04. | Kane Biotech Inc (2): Kane Biotech to resume at 7:30 a.m. PT | 1 | Stockwatch | ||
11.04. | Kane Biotech Inc (2): Kane Biotech signs agreement in principle for Stem sale | 1 | Stockwatch | ||
11.04. | Kane Biotech Inc.: Kane Biotech Announces Agreement in Principle for the Sale of its Interest in STEM Animal Health | 218 | GlobeNewswire (Europe) | WINNIPEG, Manitoba, April 11, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the "Company" or "Kane Biotech") announces today that it has reached an agreement in principle for... ► Artikel lesen | |
11.04. | Kane Biotech Inc (2): Kane Biotech halted at the open | 1 | Stockwatch | ||
26.03. | Kane Biotech Inc (2): Kane Biotech loses $5.27-million in 2023 | 3 | Stockwatch | ||
26.03. | Kane Biotech Inc.: Kane Biotech Announces Fourth Quarter and Full Year 2023 Financial Results | 182 | GlobeNewswire (Europe) | WINNIPEG, Manitoba, March 26, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the "Company" or "Kane Biotech") today announces its fourth quarter and full year 2023 financial... ► Artikel lesen | |
20.03. | Kane Biotech Inc (2): Kane extends exclusivity period on Stem offer | 1 | Stockwatch | ||
20.03. | Kane Biotech Inc.: Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health | 1 | GlobeNewswire (USA) | ||
19.03. | Kane Biotech Inc.: Kane Biotech to Release Fourth Quarter and Full Year 2023 Financial Results on March 26, 2024 - Conference Call to Follow | 1 | GlobeNewswire (USA) | ||
19.03. | Kane Biotech Inc (2): Kane Biotech to release 2023 results March 26 | 1 | Stockwatch | ||
08.03. | Kane Biotech Inc.: Kane Biotech Receives Bioscience Association Manitoba Company of the Year Award | 1 | GlobeNewswire (USA) | ||
22.02. | Kane Biotech Inc (2): Kane Biotech appoints Huizinga as executive chair | 1 | Stockwatch | ||
22.02. | Kane Biotech Inc.: Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive Chair | 167 | GlobeNewswire (Europe) | WINNIPEG, Manitoba, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the "Company" or "Kane Biotech" or "Kane") announces that at the special meeting of the shareholders... ► Artikel lesen | |
31.01. | Kane Biotech Inc (2): Kane Biotech files revyve wound gel spray patent | 1 | Stockwatch |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PAION | 0,035 | 0,00 % | Paion mit SONDERMELDUNG: Könnte der Kurs JETZT komplett drehen - Anleger müssen SOFORT reagieren! | ||
NANOREPRO | 1,695 | -6,09 % | Nanorepro braucht neue Ideen | Mitte 2020 stand die Aktie von Nanorepro bei rund einem Euro. Die Corona-Schnelltests der Gesellschaft haben dann Umsatz und Kurs der Aktie nach oben katapultiert. Im März 2021 notierte das Papier bei... ► Artikel lesen | |
4SC | 8,160 | +2,00 % | PTA-HV: 4SC AG: Einladung zur ordentlichen Hauptversammlung 2024 | DJ PTA-HV: 4SC AG: Einladung zur ordentlichen Hauptversammlung 2024
Hauptversammlung gemäß § 121 Abs. 4a AktG
Planegg-Martinsried (pta/08.05.2024/16:30) - 4SC AG, Planegg
Wertpapier-Kennnummer... ► Artikel lesen | |
PALATIN TECHNOLOGIES | 2,080 | -1,42 % | Palatin: FDA Clears IND Application For Bremelanotide Phase 2 Study | WASHINGTON (dpa-AFX) - Palatin Technologies, Inc. (PTN) announced the FDA has completed 30-day review of the investigational new drug application for the use of bremelanotide, a melanocortin... ► Artikel lesen | |
BRAIN BIOTECH | 2,800 | +0,36 % | 5 Mio. Euro Wachstumsfinanzierung für BRAIN Biotech AG | ||
BIOXXMED | 0,406 | 0,00 % | HV-Kalender: Aktionärs-Versammlungen u.a. bei bioXXmed, Shelly Group, Valneva | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
AAP IMPLANTATE | 1,320 | -0,75 % | aap Implantate: Lateinamerika-Geschäft bringt Umsatzplus | aap Implantate meldet Eckdaten für das erste Quartal 2024. Unternehmensangaben vom Montag zufolge konnte der Umsatz in dem Zeitraum von 2,96 Millionen Euro auf 3,12 Millionen Euro erhöht werden. Während... ► Artikel lesen | |
CLINUVEL | 9,280 | +0,05 % | CLINUVEL PHARMACEUTICALS LIMITED: Update - Notification of buy-back - CUV | ||
SANGAMO THERAPEUTICS | 0,522 | +1,64 % | Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results | RICHMOND, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today reported business highlights and first quarter 2024 financial results.
"Sangamo... ► Artikel lesen | |
SCORPIUS | 0,170 | +3,03 % | Scorpius Holdings, Inc.: Scorpius Holdings Appoints New VP of Business Development Shari Udoff-McDonald | ||
AETERNA ZENTARIS | 7,360 | -2,65 % | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 03.05.2024 | The following instruments on XETRA do have their first trading 03.05.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 03.05.2024
Aktien
1 ES0105777017 Puig Brands S.A.
2... ► Artikel lesen | |
BIO-GATE | 0,960 | -1,03 % | EQS-News: Bio-Gate AG: Bio-Gate veröffentlicht Geschäftsbericht 2023 und bestätigt vorläufige Zahlen | EQS-News: Bio-Gate AG
/ Schlagwort(e): Jahresbericht/Prognose
Bio-Gate veröffentlicht Geschäftsbericht 2023 und bestätigt vorläufige Zahlen
30.04.2024 / 13:27 CET/CEST
Für... ► Artikel lesen | |
EDITAS MEDICINE | 5,144 | +4,07 % | Editas Medicine, Inc.: Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting | Research includes the first-ever application of AsCas12a in vivo, optimized LNP delivery, and gene editing RNA guide modifications Data to support development of the Company's in vivo gene editing... ► Artikel lesen | |
TREVENA | 0,400 | +3,50 % | Trevena Inc expected to post a loss of 47 cents a share - Earnings Preview | ||
EVOLVA | 0,966 | -1,61 % | Adhoc: Evolva Holding SA: Shareholders of Evolva Holding SA in liquidation approve BoD proposals at AGM; revocation of liquidation and delisting also approved whereas introduction of opting-out was rejected | Evolva Holding SA / Key word(s): AGMEGM
Shareholders of Evolva Holding SA in liquidation approve BoD proposals at AGM; revocation of liquidation and delisting also approved whereas introduction... ► Artikel lesen |